Merck COVID-19 Pill

• COVID-19 pills in low supply in U.S. due to months-long manufacturing time

  The problem, in part, is that production is still being ramped up and the medicines can take anywhere from five to eight months to manufacture.

  World

  Jan 14, 2022
  
• Newly approved COVID-19 pills come with a catch. Here’s what you should know

  U.S. regulators authorized Pfizer's pill, Paxlovid, and Merck's molnupiravir this week.

  Health

  Dec 26, 2021
  
• Advertisement
• Merck’s antiviral COVID-19 pill approved by U.S. FDA for at-home use

  Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce COVID-19 hospitalizations and deaths by around 30 per cent.

  World

  Dec 23, 2021
• Advertisement
• Merck to make its COVID-19 antiviral pill in Canada, company announces

  Merck has reached an agreement with an Ontario pharmaceutical company to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.

  Health

  Dec 6, 2021
• Canada secures orders of Merck, Pfizer COVID-19 antiviral pills

  Canada has announced it has signed purchasing agreements with Pfizer and Merck for their COVID-19 antiviral pills designed to treat the virus.

  Health

  Dec 3, 2021
• Pfizer begins approval process for COVID-19 antiviral pill in Canada

  Pfizer Inc said on Wednesday it had started the real-time submission of its application seeking Health Canada's approval of its oral COVID-19 antiviral drug candidate.

  Canada

  Dec 1, 2021
• Merck’s COVID-19 pill reduces hospitalization, death risk by 30%, company says

  The company said the data on the drug molnupiravir had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.

  Health

  Nov 26, 2021
• U.K. approves Merck antiviral pill to treat COVID-19

  The U.K. is the first country to approve Merck's molnupiravir antiviral treatment for COVID-19.

  Health

  Nov 4, 2021
• Advertisement
• Merck asks U.S. FDA for emergency stamp for COVID-19 tablet

  An authorization from the U.S. Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home.

  World

  Oct 11, 2021